Please login to the form below

Not currently logged in
Email:
Password:

GAD

This page shows the latest GAD news and features for those working in and with pharma, biotech and healthcare.

Chasing the cure for Parkinson's disease

Chasing the cure for Parkinson's disease

NLX· P101 uses adeno-associated virus-mediated transfer to introduce the gene for GAD into the brain. ... GAD converts glutamate (ie main excitatory neurotransmitter) into gamma-aminobutyric acid (GABA; main inhibitory neurotransmitter).

Latest news

  • Pfizer uses augmented reflection technology for mental health campaign Pfizer uses augmented reflection technology for mental health campaign

    Pfizer uses augmented reflection technology for mental health campaign. Teams up with Anxiety UK to raise awareness of GAD. ... One of the striking images from Pfizer's video. Pfizer UK has launched a new campaign that uses augmented reflection

  • Diabetes favoured

    GAD 65 antigen based. therapy for type 1 diabetes. Ongoing phase III.

  • An unexpected turn

    Quetiapine was launched for the treatment of schizophrenia and bipolar disorders, and is currently in preregistration for the treatment of depression and generalised anxiety disorder (GAD) in the US, with supplemental ... In another trial, patients with

  • Beating the system

    NLX-P101 uses an adeno-associated virus to carry the glutamic acid decarboxylase (GAD) gene into the neurones of the subthalamic nucleus - the part of the brain that is over-stimulated

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics